Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

London School of Hygiene & Tropical Medicine Featured PhD Programmes
University of Glasgow Featured PhD Programmes
University of Hong Kong Featured PhD Programmes
University College London Featured PhD Programmes
University of Nottingham Featured PhD Programmes
"pharmacy"×
10 miles

pharmacy PhD Projects, Programs & Scholarships

We have 122 pharmacy PhD Projects, Programs & Scholarships

  • "pharmacy" ×
  • clear all
Order by 
Showing 1 to 10 of 122
  What is the role for community pharmacy in identifying and referring people with undiagnosed hepatitis C directly to secondary care? (TWIGGMU19SF)
  Dr M Twigg
Applications accepted all year round
In order to meet the WHO directive to eliminate Hepatitis1, and in line with national priorities2, hepatitis C services in England face significant challenges to diagnose the 200,000 patients in the UK expected to have hepatitis C but not under specialist care2.
  PhD Study in the School of Pharmacy and Pharmaceutical Sciences
 Applications are invited from self-funded full-time applicants to undertake a PhD in the School of Pharmacy and Pharmaceutical Sciences at the University of Sunderland.
  The development of the Liverpool School of Pharmacy: how it influenced and was influenced by regional, national and international developments in medicine
  Prof J Sheldon
Application Deadline: 11 January 2019
Fully-funded ‘Anniversary’ PhD scholarship (1 of 6). The Anniversary Scholarship offers an opportunity to undertake PhD research in the history of Liverpool John Moores University as it approaches its bicentenary in 2023.
  How the physical and social spaces within pharmacies are experienced by pharmacy service users and staff.
  Dr R Dhital
Applications accepted all year round
To design and undertake qualitative, quantitative or mixed-method research to understand how the physical and social spaces within pharmacies (community, hospital or GP pharmacies) are experienced by pharmacy service users and staff.
  Artificial Cells as Living Technology
  Prof D A Barrow, Dr O Castell
Application Deadline: 21 December 2018
The Barrow (Engineering) and Castell (Pharmacy) laboratories at Cardiff University seek motivated PhD candidates to contribute to an exciting €5M funded European collaboration in the field of synthetic biology and the development of programmable artificial cells as living technology.
  Analysing the factors that regulate expression of blood-brain barrier drug transporter proteins
  Dr J L Penny, Dr C Demonacos
Applications accepted all year round
In order to treat diseases associated with the central nervous system (CNS), e.g. cancer, Parkinson’s disease, depression, it is essential for therapeutic drugs to be able to penetrate into the brain.
  Targeting the P2X7 purinergic receptor in melanoma (STOKESLU19SF)
  Dr L Stokes, Dr C Morris
Application Deadline: 31 May 2019
There is much research into trying to regain control of cell proliferation or cell death (apoptosis) in cancer. Different strategies exist to do this and a multitude of individual receptor targets are being identified in tumour cell lines and primary cells.
  FOXA1 mutations in Lobular Breast Cancer: Reprogramming Responses to Tamoxifen
  Prof D Heery, Dr S Johnston
Applications accepted all year round
Tumours of the breast are often hormone-dependent, meaning their growth is driven by steroid hormones such as estrogen. This hormone acts upon the estrogen receptor (ER), which together with other transcription factors such as FOXA1 drives tumour growth.
  Development of chemical tools to interrogate cannabinoid receptors
  Dr A Vernall
Applications accepted all year round
Suitable for an international or New Zealand candidate to work on the design and synthesis of small molecules and chemical tools to study cannabinoid type 2 receptors.
  Designing novel composite polysaccharide nanoparticles for combined diagnosis and treatment of cancers
  Dr E Barbu, Dr A Lalatsa
Applications accepted all year round
Cancer continues to impose a vast burden with regard to financial costs as well as human suffering but the progress in its treatment is hindered by the limited selectivity and significant side-effects that the current chemotherapy demonstrates, representing a major challenge for modern drug delivery.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.